Skip to main content
Top

Drugs

Issue 4/2018

Content (11 Articles)

Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs

  • Review Article

Jonathan Jia Yuan Ong, Diana Yi-Ting Wei, Peter J. Goadsby

Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes

  • Open Access
  • Systematic Review

Hillel P. Cohen, Andrew Blauvelt, Robert M. Rifkin, Silvio Danese, Sameer B. Gokhale, Gillian Woollett

Ferric Carboxymaltose: A Review in Iron Deficiency

  • Adis Drug Evaluation

Lesley J. Scott

Benralizumab: First Global Approval

  • AdisInsight Report

A. Markham

Ertugliflozin: First Global Approval

  • AdisInsight Report

Anthony Markham

Correction to: Lonoctocog Alfa: A Review in Haemophilia A

  • Correction

Zaina T. Al-Salama, Lesley J. Scott

Correction to: Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence

  • Correction

Joshua J. Gagne, Jennifer M. Polinski, Wenlei Jiang, Sarah K. Dutcher, Jing Xie, Joyce Lii, Lisa A. Fulchino, Aaron S. Kesselheim

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images